Repligen Will Report Third Quarter Results October 27
Waltham-based life sciences firm will host a conference call to discuss its Q3 2026 financial performance.
Updated on Oct. 13, 2026 in Public Companies
Repligen Corporation will release its financial results for the third quarter ending September 30, 2026, on October 27, 2026. The company intends to issue a press release before market open, followed by an investor conference call.
Why it matters
Quarterly earnings reports serve as a vital gauge for operators in the life sciences and bioprocessing sector to evaluate market demand trends and capital expenditure shifts. These updates help businesses calibrate their own inventory planning and investment strategies based on industry performance.
Repligen will detail its quarterly financial results following the close of the period on September 30, 2026. Investors and operators can access the discussion via conference call or the company's website.
The players
Repligen Corporation
A life sciences company headquartered in Waltham that develops and manufactures bioprocessing technologies used in the production of biological drugs.
The details
The firm will release its financial results before the market opens, providing data on operations for the three months ending September 30. Following the announcement, leadership will conduct a conference call at 8:00 a.m. ET to elaborate on business updates. Domestic callers may join via (833) 461-5787, while international callers can use (585) 542-9983 with the meeting ID 877042431.
Timeline
September 30, 2026: End of the third quarter reporting period.
October 27, 2026: Press release and conference call at 8:00 a.m. ET.
Market Landscape
This scheduled update adheres to the standard disclosure cadence mandated by the Securities and Exchange Commission's periodic reporting requirements. Such filings provide a consistent rhythm for tracking industry health against broader economic benchmarks.
Operators should monitor the report for insights into bioprocessing demand that could signal broader industry growth or contraction. Watch for forward-looking guidance that may affect procurement planning in the upcoming quarters.
The takeaway
Quarterly reports provide a crucial signal for benchmarking performance against industry peers. Keep the conference call dial-in information handy if you are tracking the bioprocessing sector's health heading into the end of the year.
What happens next
Repligen Corporation will host its third quarter 2026 conference call on October 27, 2026, at 8:00 a.m. ET.
Further reading
For broader trends in industry performance, view the latest updates on Public Companies.
